Skip to main content

Table 2 Distribution of SOCS-3 and CXCR2 expression per histological grade in patients with astrocytomas.

From: Expression of Interleukin-8 Receptor CXCR2 and Suppressor of Cytokine Signaling-3 in Astrocytic Tumors

 

Grade II

Grade III

Grade IV

Total

SOCS-3 (%)

3.5 (0–70)

1.75 (0–70)

30 (0–95)

20 (0–95)

CXCR2 (%)

0(0–5)

0.25 (0–5)

0.5 (0–70)

0(0–70)

  1. Data are medians (range).